MLYS   $23.65  -1.74% Market Closed After Close 23.65 0.0

Mineralys Therapeutics, Inc.
Total Cash 311.12M
totalCashPerShare 6.257
EBITDA
Total Debt 0.00
quickRatio 10.956
currentRatio 11.198
Total Revenue
debtToEquity
Revenue/Share
ROA -0.27578
ROE -0.41617
grossProfits
freeCashflow -52.32M
operatingCashflow -97.30M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 354.23M
forwardPE -3.955882
floatShares 23.84M
sharesOutstanding 49.73M
sharesShort 1.61M
sharesShortPriorMonth 1.47M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.03%
heldPercentInstitutions 1.01%
Short Ratio help_outline 11.47%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 5.836
Price To Book help_outline 2.30
earningsQuarterlyGrowth
netIncomeToCommon -119.67M
trailingEps -2.76%
forwardEps -3.40%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.83 3Q 2024
institutionsCount 144
lastUpdated Nov. 2, 2024, 4:07 a.m.